These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 901735)

  • 21. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lignocaine concentrations associated with extradural analgesia in patients with and without multiple organ failure.
    Putensen C; Lingnau W; Putensen-Himmer G; Herold M
    Br J Anaesth; 1992 Nov; 69(5):513-6. PubMed ID: 1467084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of age on lignocaine pharmacokinetics in young puppies.
    Hastings CL; Brown TC; Eyres RL; Oppenheim RC
    Anaesth Intensive Care; 1986 May; 14(2):135-9. PubMed ID: 3740386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
    Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
    Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of lignocaine in children following caudal anaesthesia.
    Ecoffey C; Desparmet J; Berdeaux A; Maury M; Giudicelli JF; Saint-Maurice C
    Br J Anaesth; 1984 Dec; 56(12):1399-402. PubMed ID: 6498050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.
    Burm AG; Vermeulen NP; van Kleef JW; de Boer AG; Spierdijk J; Breimer DD
    Clin Pharmacokinet; 1987 Sep; 13(3):191-203. PubMed ID: 3665324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quick, sensitive high-performance liquid chromatography assay for monoethylglycinexylidide and lignocaine in serum/plasma using solid-phase extraction.
    Chen Y; Potter JM; Ravenscroft PJ
    Ther Drug Monit; 1992 Aug; 14(4):317-21. PubMed ID: 1519306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of lidocaine clearance in elderly male subjects.
    Abernethy DR; Greenblatt DJ
    J Cardiovasc Pharmacol; 1983; 5(6):1093-6. PubMed ID: 6196560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: relationships between myocardial pharmacokinetics and pharmacodynamics.
    Huang YF; Upton RN; Runciman WB
    Br J Anaesth; 1993 May; 70(5):556-61. PubMed ID: 8318331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
    Drayer DE; Lorenzo B; Werns S; Reidenberg MM
    Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid assessment of lidocaine in cardiac patients by enzyme immunoassay.
    Miller E; Walberg C; Haywood LJ
    Ther Drug Monit; 1981; 3(1):85-9. PubMed ID: 7015581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lignocaine concentration following nebulization for awake intubation.
    Parkes SB; Butler CS; Muller R
    Anaesth Intensive Care; 1997 Aug; 25(4):369-71. PubMed ID: 9288379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.